Tian Y, Zheng X, Xu Y
Department of Surgery, First Affiliated Hospital, China Medical University, Shenyang.
Zhonghua Wai Ke Za Zhi. 1996 Dec;34(12):740-3.
Randomized controlled clinical study of Sulperazon (Sulbactam/Cefoperazon) was made in the surgical field. 35 cases were treated with Sulperazon and 32 cases with Ceftazidime. In the Sulperazon group (35 patients), the effective rate was 88.6% as compared with 90.6% of the patients in the Ceftazidime group (32 patients) (P > 0.05). The bacterial eradication rate was 86.2% in the Sulperazon group as compared with 88.5% in the Ceftazidime group. No significant difference was noted in both groups. In the Sulperazon group, side effects were not observed except nausea in one case.
对舒普深（舒巴坦/头孢哌酮）进行了外科领域的随机对照临床研究。35例患者接受舒普深治疗，32例患者接受头孢他啶治疗。舒普深组（35例患者）有效率为88.6%，头孢他啶组（32例患者）有效率为90.6%（P>0.05）。舒普深组细菌清除率为86.2%，头孢他啶组为88.5%。两组均未观察到显著差异。在舒普深组，除1例出现恶心外，未观察到副作用。
